Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ataluren in nonsense mutation aniridia
NCT02647359Phase 2Completed
- Sponsor
- PTC Therapeutics, Inc.
- Start
- Jan 2016
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of ataluren in aniridia, sponsored by PTC Therapeutics, Inc.. Started Jan 2016; status: completed.
02
Drugs
ataluren
03
Conditions
aniridia
Beyond the preview
Go deeper on NCT02647359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02647359.